-
2022/08/04
Consolidated Financial Results for the Three Months Ended June 30, 2022 (Under Japanese GAAP)
（394KB）
-
2022/07/22
Launched a CDMO service using CereAAV™,
a brain-tropic AAV vector for gene therapy
読む Launched a CDMO service using CereAAV™, a brain-tropic AAV vector for gene therapy
-
2022/07/06
[Delayed] Corporate Governance Report
（770KB）
-
2022/06/13
Notice of the 20th Annual General Meeting of Shareholders
（208KB）
-
2022/06/01
Takara Bio to Present Clinical Data from Investigator-Initiated Trial in Canada of NY-ESO-1・siTCR™ Gene Therapy at ASCO2022
【Poster Posted】